June 2020: Sleep Review
An Investigational Tetanus Toxin-Based Sleep-Disordered Breathing Therapy Is In the Works
August 2020: Wholesale Investor
Snoretox announces successful capital raise
September 2020: BioMelbourne Network
Snoretox receives “Barrier to Innovation” Waiver from FDA (Center for Veterinary Medicine) for Innovative Medical Breakthrough Therapy.
May 2021: BioMelbourne Network
Snoretox wins MRFF Frontier Grant
August 2025: DVM 360
BOAS treatment in development is recognized with Innovation Award
September 2025: Spontaneous media reporting of one of our trial participants.
Breathing easier? Snore thing!
Anna Shreeves (photo by Jason Edwards)
You’ve heard of Botox but it’s time to be introduced to Snoretox, a potentially life-changing drug for dogs that struggle to breathe properly.
This seven-year-old pug, Pugtato, has brachycephalic obstructive airway syndrome, an affliction that often affects the breed.
For many of these flat-faced dogs, there has been no way to remedy their breathing, until now.
A clinical trial led by Dr Arthur House at Peninsula Vet Emergency & Referral Hospital with RMIT University chose Pugtato as its test subject.
Following some preliminary tests, the pug received two injections of Snoretox. Two months on, the effects are said to be remarkable.
Joanna Herceg, Pugtato’s owner and founder of Pug Rescue Victoria, said his improvement had been “overwhelmingly drastic.”
Before Snoretox, he was an “agitated” dog that would struggle to settle. Now, she can barely recognise him. His energy has increased, he is breathing well and he seems like an all-round contented dog.
“I will try to do everything for these dogs, and it’s heartbreaking to watch them suffer from not being able to breathe properly,” Ms Herceg said.
“He has gone from an unadoptable dog to a really awesome adoptable dog.”
pugrescue.org.au
